- Home
- MIST vs STIM Comparison
MIST vs STIM Comparison
Compare MIST & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MIST
- STIM
- Stock Information
- Founded
- MIST 2003
- STIM 2003
- Country
- MIST Canada
- STIM United States
- Employees
- MIST N/A
- STIM N/A
- Industry
- MIST Biotechnology: Pharmaceutical Preparations
- STIM Medical/Dental Instruments
- Sector
- MIST Health Care
- STIM Health Care
- Exchange
- MIST Nasdaq
- STIM Nasdaq
- Market Cap
- MIST 100.3M
- STIM 83.5M
- IPO Year
- MIST N/A
- STIM 2018
- Fundamental
- Price
- MIST $1.98
- STIM $2.46
- Analyst Decision
- MIST Strong Buy
- STIM Buy
- Analyst Count
- MIST 3
- STIM 4
- Target Price
- MIST $13.00
- STIM $4.67
- AVG Volume (30 Days)
- MIST 636.8K
- STIM 896.9K
- Earning Date
- MIST 11-12-2024
- STIM 03-04-2025
- Dividend Yield
- MIST N/A
- STIM N/A
- EPS Growth
- MIST N/A
- STIM N/A
- EPS
- MIST N/A
- STIM N/A
- Revenue
- MIST N/A
- STIM $72,711,000.00
- Revenue This Year
- MIST N/A
- STIM $1.97
- Revenue Next Year
- MIST N/A
- STIM $7.96
- P/E Ratio
- MIST N/A
- STIM N/A
- Revenue Growth
- MIST N/A
- STIM 5.03
- 52 Week Low
- MIST $1.12
- STIM $0.52
- 52 Week High
- MIST $2.75
- STIM $5.07
- Technical
- Relative Strength Index (RSI)
- MIST 49.21
- STIM 75.35
- Support Level
- MIST $1.92
- STIM $1.40
- Resistance Level
- MIST $2.07
- STIM $2.80
- Average True Range (ATR)
- MIST 0.20
- STIM 0.28
- MACD
- MIST -0.03
- STIM 0.08
- Stochastic Oscillator
- MIST 9.41
- STIM 77.18
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to terminate episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).
About STIM Neuronetics Inc.
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.